BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11567222)

  • 21. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
    Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
    Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA
    Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of fragile histidine triad expression in prostate carcinoma.
    Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
    Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Kang JS; Calvo BF; Maygarden SJ; Caskey LS; Mohler JL; Ornstein DK
    Clin Cancer Res; 2002 Jan; 8(1):117-23. PubMed ID: 11801547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
    Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.
    Huang J; Powell WC; Khodavirdi AC; Wu J; Makita T; Cardiff RD; Cohen MB; Sucov HM; Roy-Burman P
    Cancer Res; 2002 Aug; 62(16):4812-9. PubMed ID: 12183441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K
    Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice.
    Scherl A; Li JF; Cardiff RD; Schreiber-Agus N
    Prostate; 2004 Jun; 59(4):448-59. PubMed ID: 15065094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
    Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C
    Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.